Matches in Wikidata for { <http://www.wikidata.org/entity/Q95834034> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q95834034 description "article scientifique publié en 2020" @default.
- Q95834034 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95834034 description "scientific article published on 27 May 2020" @default.
- Q95834034 description "wetenschappelijk artikel" @default.
- Q95834034 description "наукова стаття, опублікована 27 травня 2020" @default.
- Q95834034 name "Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials" @default.
- Q95834034 name "Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials" @default.
- Q95834034 type Item @default.
- Q95834034 label "Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials" @default.
- Q95834034 label "Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials" @default.
- Q95834034 prefLabel "Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials" @default.
- Q95834034 prefLabel "Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials" @default.
- Q95834034 P1433 Q95834034-B2AF3B4B-B644-49A9-B9E4-675EA497FE62 @default.
- Q95834034 P1476 Q95834034-911813DE-696E-484A-8C89-131C5C06F4D3 @default.
- Q95834034 P2093 Q95834034-454065FF-1780-4F55-8093-90933ED5FCC9 @default.
- Q95834034 P2093 Q95834034-9FE39FE3-F087-408A-84C8-294DA7FFA11D @default.
- Q95834034 P2093 Q95834034-C1595078-1758-4096-9C0A-061EE5D2EFC8 @default.
- Q95834034 P2093 Q95834034-D92D5B16-299C-4128-A1E2-DDE7C540AB28 @default.
- Q95834034 P304 Q95834034-68B84993-20CF-45FD-B3CC-D9B8E2737206 @default.
- Q95834034 P31 Q95834034-0950AF10-6AB1-4223-BA6D-8B31A07E2F16 @default.
- Q95834034 P356 Q95834034-BF2BBC93-BFB4-487B-A93C-9A6853DE6528 @default.
- Q95834034 P50 Q95834034-2001F1D1-891C-4A1F-8B9D-8D9E9A37FFA5 @default.
- Q95834034 P577 Q95834034-FFFA716F-2CB1-460C-9D9A-926ED4E1F3D1 @default.
- Q95834034 P698 Q95834034-2DC67A63-9F74-4943-BA84-088559698272 @default.
- Q95834034 P921 Q95834034-5EF4F8F8-4264-4785-8D45-5178F1603E7A @default.
- Q95834034 P921 Q95834034-83E900C9-28EC-4232-9774-77D732CC7E86 @default.
- Q95834034 P356 14728214.2020.1769067 @default.
- Q95834034 P698 32456491 @default.
- Q95834034 P1433 Q5421207 @default.
- Q95834034 P1476 "Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials" @default.
- Q95834034 P2093 "Andrea Barp" @default.
- Q95834034 P2093 "Christian Lunetta" @default.
- Q95834034 P2093 "Francesca Gerardi" @default.
- Q95834034 P2093 "Valeria Ada Sansone" @default.
- Q95834034 P304 "1-20" @default.
- Q95834034 P31 Q13442814 @default.
- Q95834034 P356 "10.1080/14728214.2020.1769067" @default.
- Q95834034 P50 Q91110174 @default.
- Q95834034 P577 "2020-05-27T00:00:00Z" @default.
- Q95834034 P698 "32456491" @default.
- Q95834034 P921 Q206901 @default.
- Q95834034 P921 Q42824440 @default.